1. Home
  2. ELVR vs XGN Comparison

ELVR vs XGN Comparison

Compare ELVR & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVR
  • XGN
  • Stock Information
  • Founded
  • ELVR 2000
  • XGN 2002
  • Country
  • ELVR Australia
  • XGN United States
  • Employees
  • ELVR N/A
  • XGN N/A
  • Industry
  • ELVR Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • XGN Medical Specialities
  • Sector
  • ELVR Industrials
  • XGN Health Care
  • Exchange
  • ELVR Nasdaq
  • XGN Nasdaq
  • Market Cap
  • ELVR 254.1M
  • XGN 253.9M
  • IPO Year
  • ELVR N/A
  • XGN 2019
  • Fundamental
  • Price
  • ELVR $24.34
  • XGN $11.85
  • Analyst Decision
  • ELVR
  • XGN Strong Buy
  • Analyst Count
  • ELVR 0
  • XGN 6
  • Target Price
  • ELVR N/A
  • XGN $12.83
  • AVG Volume (30 Days)
  • ELVR 113.3K
  • XGN 234.3K
  • Earning Date
  • ELVR 10-29-2025
  • XGN 11-04-2025
  • Dividend Yield
  • ELVR N/A
  • XGN N/A
  • EPS Growth
  • ELVR N/A
  • XGN N/A
  • EPS
  • ELVR N/A
  • XGN N/A
  • Revenue
  • ELVR $146,440,045.00
  • XGN $58,862,000.00
  • Revenue This Year
  • ELVR $9.75
  • XGN $22.50
  • Revenue Next Year
  • ELVR $8.82
  • XGN $14.19
  • P/E Ratio
  • ELVR N/A
  • XGN N/A
  • Revenue Growth
  • ELVR 11.20
  • XGN 3.89
  • 52 Week Low
  • ELVR $15.55
  • XGN $2.38
  • 52 Week High
  • ELVR $33.36
  • XGN $12.23
  • Technical
  • Relative Strength Index (RSI)
  • ELVR N/A
  • XGN 67.05
  • Support Level
  • ELVR N/A
  • XGN $11.58
  • Resistance Level
  • ELVR N/A
  • XGN $12.23
  • Average True Range (ATR)
  • ELVR 0.00
  • XGN 0.34
  • MACD
  • ELVR 0.00
  • XGN -0.02
  • Stochastic Oscillator
  • ELVR 0.00
  • XGN 73.79

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Share on Social Networks: